Literature DB >> 23212755

Extragenetic factors and clinical penetrance of DYT1 dystonia: an exploratory study.

D Martino1, A Gajos, V Gallo, L Cif, P Coubes, M Tinazzi, S A Schneider, M Fiorio, G Zorzi, N Nardocci, Y Ben-Shlomo, M J Edwards, K P Bhatia.   

Abstract

Factors modifying the clinical penetrance of DYT1 dystonia are incompletely defined. Particularly, the contribution of extragenetic factors has been subject to only limited investigation and remains largely unexplored. A possible effect of childhood infections has been proposed, and the effect of other factors, such as perinatal adversity and trauma, has not been systematically investigated. We performed an exploratory analysis of the exposure to perinatal adversity, childhood infections, general anaesthesia and trauma comparing 39 manifesting carriers of the ∆GAG mutation, 23 non-manifesting carriers and 48 non-carriers from a multi-centre European series of 28 families with DYT1 dystonia, by means of a self-completed questionnaire and clinical interview. Detailed information on perinatal adversities (pre-term birth, complications at natural delivery, urgent caesarean section), previous childhood infections, and prior general anaesthesia or physical trauma was recorded. A positive association between a history of complications of vaginal delivery and manifestation of dystonia was detected, which was not confounded by age, gender, or education level (odds ratio 8.47, 95 % confidence interval 1.45-49.4, p = 0.02). We could not observe any significant association between presence of dystonia and the other investigated variables. Comparing non-manifesting carriers to non-carriers, the presence of the ∆GAG mutation per se was not associated with any of the environmental exposures explored. Perinatal adversities might modulate the clinical penetrance of DYT1 dystonia; their interaction with known genetic factors modifying penetrance of this condition should be investigated in new, larger collaborative studies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23212755     DOI: 10.1007/s00415-012-6765-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  12 in total

1.  Diagnostic criteria for dystonia in DYT1 families.

Authors:  S B Bressman; D Raymond; K Wendt; R Saunders-Pullman; D De Leon; S Fahn; L Ozelius; N Risch
Journal:  Neurology       Date:  2002-12-10       Impact factor: 9.910

2.  Delayed-onset dystonia in patients with "static" encephalopathy.

Authors:  R E Burke; S Fahn; A P Gold
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-09       Impact factor: 10.154

3.  Measles infection and Parkinson's disease.

Authors:  A J Sasco; R S Paffenbarger
Journal:  Am J Epidemiol       Date:  1985-12       Impact factor: 4.897

Review 4.  Unusual phenotypes in DYT1 dystonia: a report of five cases and a review of the literature.

Authors:  Mark Edwards; Nicholas Wood; Kailash Bhatia
Journal:  Mov Disord       Date:  2003-06       Impact factor: 10.338

5.  Delayed-onset dystonia due to perinatal asphyxia: a prospective study.

Authors:  Igor Petrović; Christine Klein; Vladimir S Kostić
Journal:  Mov Disord       Date:  2007-12       Impact factor: 10.338

6.  Stereotactic MRI in DYT1 dystonia: focal signal abnormalities in the basal ganglia do not contraindicate deep brain stimulation.

Authors:  S Gavarini; N Vayssière; P Delort; L Cif; B Biolsi; C Tancu; X Vasques; S Plagnol; A Bonafe; P Coubes
Journal:  Stereotact Funct Neurosurg       Date:  2008-05-13       Impact factor: 1.875

7.  The p.Asp216His TOR1A allele effect is not found in the French population.

Authors:  Mélissa Yana Frédéric; Fabienne Clot; Arnaud Blanchard; Claire-Marie Dhaenens; Gaëtan Lesca; Laura Cif; Alexandra Dürr; Marie Vidailhet; Bernard Sablonniere; Alain Calender; Maria Martinez; Nicolas Molinari; Alexis Brice; Mireille Claustres; Sylvie Tuffery-Giraud; Gwenaëlle Collod-Beroud
Journal:  Mov Disord       Date:  2009-04-30       Impact factor: 10.338

8.  Parkinson's disease and the environment in early life.

Authors:  C N Martyn; C Osmond
Journal:  J Neurol Sci       Date:  1995-10       Impact factor: 3.181

9.  Intragenic Cis and Trans modification of genetic susceptibility in DYT1 torsion dystonia.

Authors:  Neil J Risch; Susan B Bressman; Geetha Senthil; Laurie J Ozelius
Journal:  Am J Hum Genet       Date:  2007-04-27       Impact factor: 11.025

10.  Delayed-onset dystonia due to perinatal or early childhood asphyxia.

Authors:  M H Saint Hilaire; R E Burke; S B Bressman; M F Brin; S Fahn
Journal:  Neurology       Date:  1991-02       Impact factor: 9.910

View more
  6 in total

Review 1.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Authors:  David N Cooper; Michael Krawczak; Constantin Polychronakos; Chris Tyler-Smith; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2013-07-03       Impact factor: 4.132

2.  A role for cerebellum in the hereditary dystonia DYT1.

Authors:  Rachel Fremont; Ambika Tewari; Chantal Angueyra; Kamran Khodakhah
Journal:  Elife       Date:  2017-02-15       Impact factor: 8.140

3.  Peripheral trauma and risk of dystonia: What are the evidences and potential co-risk factors from a population insurance database?

Authors:  Antonella Macerollo; Mark J Edwards; Hui-Chun Huang; Ming-Kuei Lu; Hsuan-Ju Chen; Chon-Haw Tsai; Jui Cheng Chen
Journal:  PLoS One       Date:  2019-05-10       Impact factor: 3.240

Review 4.  Challenges in Clinicogenetic Correlations: One Gene - Many Phenotypes.

Authors:  Francesca Magrinelli; Bettina Balint; Kailash P Bhatia
Journal:  Mov Disord Clin Pract       Date:  2021-03-02

Review 5.  The genetics of dystonia: new twists in an old tale.

Authors:  Gavin Charlesworth; Kailash P Bhatia; Nicholas W Wood
Journal:  Brain       Date:  2013-06-17       Impact factor: 13.501

Review 6.  The Role of Torsin AAA+ Proteins in Preserving Nuclear Envelope Integrity and Safeguarding Against Disease.

Authors:  Anthony J Rampello; Sarah M Prophet; Christian Schlieker
Journal:  Biomolecules       Date:  2020-03-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.